Cargando…
Correction: I(1) Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline
Autores principales: | Barac, Yaron D., Bar-Am, Orit, Liani, Esti, Amit, Tamar, Frolov, Luba, Ovcharenko, Elena, Angel, Itzchak, Youdim, Moussa B. H., Binah, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677844/ http://dx.doi.org/10.1371/annotation/9dae97ef-4a68-47b2-a8f5-fb953ebe877c |
Ejemplares similares
-
I(1) Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline
por: Barac, Yaron D., et al.
Publicado: (2012) -
The cardioprotective efficacy of TVP1022 against ischemia/reperfusion injury and cardiac remodeling in rats
por: Malka, Assaf, et al.
Publicado: (2016) -
Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
por: Youdim, Moussa B.H.
Publicado: (2013) -
2-Imidazoline Nitroxide Derivatives of Cymantrene
por: Maryunina, Kseniya, et al.
Publicado: (2022) -
Rasagiline in treatment of Parkinson’s disease
por: Nayak, Lakshmi, et al.
Publicado: (2008)